1. Home
  2. OCSL vs HROW Comparison

OCSL vs HROW Comparison

Compare OCSL & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • HROW
  • Stock Information
  • Founded
  • OCSL 2007
  • HROW 1998
  • Country
  • OCSL United States
  • HROW United States
  • Employees
  • OCSL N/A
  • HROW 382
  • Industry
  • OCSL Finance: Consumer Services
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCSL Finance
  • HROW Health Care
  • Exchange
  • OCSL Nasdaq
  • HROW Nasdaq
  • Market Cap
  • OCSL 1.2B
  • HROW 1.4B
  • IPO Year
  • OCSL 2008
  • HROW N/A
  • Fundamental
  • Price
  • OCSL $13.93
  • HROW $38.79
  • Analyst Decision
  • OCSL
  • HROW Strong Buy
  • Analyst Count
  • OCSL 0
  • HROW 7
  • Target Price
  • OCSL N/A
  • HROW $64.67
  • AVG Volume (30 Days)
  • OCSL 604.4K
  • HROW 671.7K
  • Earning Date
  • OCSL 08-05-2025
  • HROW 08-11-2025
  • Dividend Yield
  • OCSL 11.49%
  • HROW N/A
  • EPS Growth
  • OCSL N/A
  • HROW N/A
  • EPS
  • OCSL 0.55
  • HROW N/A
  • Revenue
  • OCSL $334,099,000.00
  • HROW $227,661,000.00
  • Revenue This Year
  • OCSL N/A
  • HROW $46.17
  • Revenue Next Year
  • OCSL N/A
  • HROW $39.97
  • P/E Ratio
  • OCSL $25.46
  • HROW N/A
  • Revenue Growth
  • OCSL N/A
  • HROW 47.69
  • 52 Week Low
  • OCSL $12.50
  • HROW $20.85
  • 52 Week High
  • OCSL $17.16
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 55.43
  • HROW 60.95
  • Support Level
  • OCSL $13.59
  • HROW $37.09
  • Resistance Level
  • OCSL $13.90
  • HROW $40.41
  • Average True Range (ATR)
  • OCSL 0.20
  • HROW 2.55
  • MACD
  • OCSL 0.05
  • HROW 0.11
  • Stochastic Oscillator
  • OCSL 97.22
  • HROW 83.24

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: